These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 3643162

  • 1. Modification of hepatitis B virus infection by recombinant leukocyte alpha A interferon.
    Hess G, Meyer zum Büschenfelde KH.
    Immunobiology; 1986 Sep; 172(3-5):255-61. PubMed ID: 3643162
    [Abstract] [Full Text] [Related]

  • 2. [Treatment of hepatitis B surface antigen (HBsAg)-positive chronic hepatitis with recombinant alpha-A-interferon. Results of a phase II study].
    Hess G, Weber C, Rossol S, Voth R, Drees N, Meyer zum Büschenfelde KH.
    Z Gastroenterol; 1988 Jul; 26(7):380-7. PubMed ID: 3223006
    [Abstract] [Full Text] [Related]

  • 3. Treatment of chronic hepatitis B (HBeAg-HBV DNA-positive) with lymphoblastoid alpha interferon with or without corticosteroids: short- and long-term follow-up.
    Zavaglia C, Bottelli R, Bellati G, Asti L, Mondazzi L, Iamoni G, Zanetti A, Tanzi E, Fesce E, Gelosa F, Maggi G, Ideo G.
    Ital J Gastroenterol; 1996 Jul; 28(6):324-31. PubMed ID: 8891847
    [Abstract] [Full Text] [Related]

  • 4. [Effect of interferon on hepatitis B virus infection in patients with chronic active hepatitis].
    Hinoue Y, Unoura M, Kato Y, Kobayashi K, Hattori N.
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):205-11. PubMed ID: 6696458
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Treatment of fourteen chronic active HBsAg+, HBeAg+ hepatitis patients with low dose natural human interferon alpha administered orally.
    Zielińska W, Paszkiewicz J, Korczak A, Własiuk M, Zółtowska A, Szutowicz A, Cummins JM, Georgiades JA.
    Arch Immunol Ther Exp (Warsz); 1993 Feb; 41(3-4):241-51. PubMed ID: 8129568
    [Abstract] [Full Text] [Related]

  • 8. [The combined treatment with prednisolone and recombinant alpha 2-interferon of patients with chronic hepatitis B: the factors influencing the immune response].
    Fedorchenko SV, Vovk AD, Rybalko SL.
    Ter Arkh; 1994 Feb; 66(2):24-9. PubMed ID: 8160138
    [Abstract] [Full Text] [Related]

  • 9. Lymphoblastoid interferon therapy of chronic HBV infection. A comparison of 12 vs. 24 weeks of thrice weekly treatment.
    Scully LJ, Shein R, Karayiannis P, McDonald JA, Thomas HC.
    J Hepatol; 1987 Aug; 5(1):51-8. PubMed ID: 3655310
    [Abstract] [Full Text] [Related]

  • 10. Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV-III antibodies to recombinant alpha-interferon.
    McDonald JA, Caruso L, Karayiannis P, Scully LJ, Harris JR, Forster GE, Thomas HC.
    Hepatology; 1987 Aug; 7(4):719-23. PubMed ID: 3038722
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Alpha-interferon antiviral treatment in 100 patients with chronic hepatitis B].
    Janssen HL, Berk L, de Man RA, Heijtink RA, Schalm SW.
    Ned Tijdschr Geneeskd; 1992 Apr 25; 136(17):835-9. PubMed ID: 1522928
    [Abstract] [Full Text] [Related]

  • 13. Permanent inhibition of viral replication induced by low dosage of human leukocyte interferon in patients with chronic hepatitis B.
    Pastore G, Santantonio T, Monno L, Milella M, Luchena N, Angarano G.
    Hepatogastroenterology; 1988 Apr 25; 35(2):57-61. PubMed ID: 3371847
    [Abstract] [Full Text] [Related]

  • 14. Therapy for hepatitis B virus infection.
    Perrillo RP, Mason AL.
    Gastroenterol Clin North Am; 1994 Sep 25; 23(3):581-601. PubMed ID: 7527374
    [Abstract] [Full Text] [Related]

  • 15. Immunoglobulin M antibody to hepatitis B core antigen (IgM anti-HBc) as a marker of interferon therapy in patients with persistent hepatitis B virus infection.
    Nakajima E, Tsuji T, Kachi K, Kagawa K, Okanoue T, Takino T, Yamada A, Imanishi J.
    Biken J; 1987 Mar 25; 30(1):17-23. PubMed ID: 3675547
    [Abstract] [Full Text] [Related]

  • 16. Transient increase of HBsAg levels following human IFN alpha treatment signalises the patient's response in chronic active hepatitis B.
    Stancek D, Hajnická V, Blaskovicová H, Sudová J, Laktis K, Janota S, Jezek P.
    Acta Virol; 1990 Sep 25; 34(5):457-66. PubMed ID: 1981456
    [Abstract] [Full Text] [Related]

  • 17. [Leukinferon in the treatment of severe forms of acute hepatitis B].
    Botsvadze ESh, Kuznetsov VP, Gogichaĭshvili ShSh.
    Ter Arkh; 1989 Sep 25; 61(11):50-4. PubMed ID: 2633393
    [No Abstract] [Full Text] [Related]

  • 18. Interferon treatment of anti-HBe positive and HBV DNA positive chronic hepatitis B.
    Alberti A, Fattovich G, Pontisso P, Brollo L, Belussi F, Ruol A.
    Chemioterapia; 1988 Dec 25; 7 Suppl 3():15-9. PubMed ID: 3073869
    [Abstract] [Full Text] [Related]

  • 19. Treatment of hepatitis B surface antigen (HBsAg)-positive chronic hepatitis with recombinant leucocyte alpha-A interferon.
    Hess G, Gerlich W, Slusarczyk J, Hütteroth TH, Meyer zum Büschenfelde KH.
    J Hepatol; 1986 Dec 25; 3 Suppl 2():S245-51. PubMed ID: 3598157
    [Abstract] [Full Text] [Related]

  • 20. Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro.
    Vincent IE, Lucifora J, Durantel D, Hantz O, Chemin I, Zoulim F, Trepo C.
    Antivir Ther; 2009 Dec 25; 14(1):131-5. PubMed ID: 19320247
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.